Classification
- Anatomical main groupBBlood and blood-forming organs
- Therapeutic subgroupB01
- Pharmacological subgroupB01A
- Chemical subgroupB01AC
- Chemical substanceB01AC16Eptifibatide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 14 registrations
- Eptifibatide Injection0.75 MG / ML · Solution · Juno Pharma Canada INC.
- Eptifibatide Injection2 MG / ML · Solution · Juno Pharma Canada INC.
- Eptifibatide Injection0.75 MG / ML · Solution · Strides Pharma Canada INC
- Eptifibatide Injection2 MG / ML · Solution · Strides Pharma Canada INC
Spain
AEMPS · 4 registrations
At a glance
- ATC code
- B01AC16
- ATC group
- Blood and blood-forming organs
- Registers
- 8
- Historical lists
- 1
- Registrations
- 36
- With their own page
- 16
- Companies
- 15
All medicines with Eptifibatide
Human medicines from every register that match Eptifibatide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
36 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Eptifibatide | United States | 2MG/ML, 75MG/100ML | injectable | Marketed | Usv |
| Eptifibatide Accord | European Union | Authorised | Accord Healthcare S.L.U. | ||
| Eptifibatide Injection | Canada | 0.75 MG / ML | Solution | Marketed | Juno Pharma Canada INC. |
| Eptifibatide Injection | Canada | 2 MG / ML | Solution | Marketed | Juno Pharma Canada INC. |
| Eptifibatide Injection | Canada | 2 MG / ML | Solution | Authorised | Strides Pharma Canada INC |
| Eptifibatide Injection | Canada | 0.75 MG / ML | Solution | Authorised | Strides Pharma Canada INC |
| Eptifibatide Viatris | New Zealand | Inj 2 mg per ml, 10 ml vial | Funded | ||
| Eptifibatide Viatris | New Zealand | Inj 750 mcg per ml, 100 ml vial | Funded | ||
| Eptifibatide Accord 2 mg/ml, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Accord Healthcare S.L.U. | |
| Eptifibatide Accord 0,75 mg/ml oplossing voor infusie | Netherlands | Oplossing voor infusie | Authorised | Accord Healthcare S.L.U. | |
| Eptifibatide AFTPharm 2 mg/ml oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | AFT Pharmaceuticals (EUR) Limited | |
| Eptifibatide AFTPharm 0,75 mg/ml oplossing voor infusie | Netherlands | Oplossing voor infusie | Authorised | AFT Pharmaceuticals (EUR) Limited | |
| Eptifibatid Accord | Croatia | Marketed | |||
| Integrilin | United States | 2MG/ML, 75MG/100ML | injectable | Not marketed | MSD Sub Merck |
| Eptifibatida Accord 2 MG/ML Solucion Inyectable Efg | Spain | 2 mg | solución inyectable | Authorised | Accord Healthcare S.L.U. |
| Eptifibatida Accord 0,75 MG/ML Solucion Para Perfusion Efg | Spain | 0,75 mg | solución para perfusión | Authorised | Accord Healthcare S.L.U. |
| Eptifibatide Injection | Canada | 2 MG / ML | Solution | Cancelled | Accord Healthcare INC |
| Eptifibatide Injection | Canada | 0.75 MG / ML | Solution | Cancelled | Teva Canada Limited |
| Eptifibatide Injection | Canada | 2 MG / ML | Solution | Cancelled | Teva Canada Limited |
| Eptifibatide Injection | Canada | 0.75 MG / ML | Solution | Cancelled | Fresenius Kabi Canada LTD |
| Eptifibatide Injection | Canada | 2 MG / ML | Solution | Cancelled | Omega Laboratories Limited |
| Eptifibatide Injection | Canada | 0.75 MG / ML | Solution | Cancelled | Accord Healthcare INC |
| Eptifibatide Injection | Canada | 2 MG / ML | Solution | Cancelled | Fresenius Kabi Canada LTD |
| Eptifibatide Injection | Canada | 0.75 MG / ML | Solution | Cancelled | Omega Laboratories Limited |
| EPTIFIBATIDE ACCORD 2 mg/ml | Romania | 2 mg/ml | sol. perf. | Status unknown | Accord Healthcare S.L.U. |